MichaelDTarantinoMD

Clotting Disorder, Hematologic Oncology, Hemophilia & Bleeding Disorder

Medical Director and President, The Bleeding and Clotting Disorders Institute

Dr. Tarantino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
427 W Northmoor Rd
Peoria, IL 61614
Phone+1 309-692-5337

Fax+1 309-693-3913

Dr. Michael Tarantino is a hematologist in Peoria, IL and is affiliated with multiple hospitals in the area, including UnityPoint Health - Peoria, OSF Saint Francis Medical Center, and UnityPoint Health - Proctor. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 30 years. He specializes in clotting disorder, hematologic oncology, and hemophilia & bleeding disorder and is experienced in amyloidosis, hematologic oncology, platelet disorders, myelodysplasia, and myelofibrosis.

University of Wisconsin Hospitals and ClinicsFellowship, Pediatric Hematology/Oncology, 1990 - 1993
University of Arizona College of Medicine-TucsonResidency, Pediatrics, 1987 - 1990
University of Wisconsin School of Medicine & Public HealthClass of 1987

PubMed

41 citations
Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia.
Paul E. Monahan, Claude Negrier, Michael D. Tarantino, Leonard A. Valentino, Federico Mingozzi
Journal of Clinical Medicine. 2021-06-02
6 citations
Clinical overview and practical considerations for optimizing romiplostim therapy in patients with immune thrombocytopenia
David J. Kuter, Michael D. Tarantino, Tatiana Lawrence
Blood Reviews. 2021-02-27
294 citations
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
Eun-Ju Lee, Douglas B. Cines, Terry Gernsheimer, Craig M. Kessler, Marc Michel
American Journal of Hematology. 2021-05-01

Journal Articles

An Outbreak of Synthetic Cannabinoid–Associated Coagulopathy in Illinois
Annia Martial, Michael D Tarantino, Jonathan C Roberts, Amar H Kelkar, Harsha Moole, The New England Journal of Medicine

Abstracts/Posters

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients
Michael D. Tarantino, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome
Michael D. Tarantino, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Clinical Careers in Hematology (Private Practice Careers)
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Career-Development Lunch Sessions: Clinical Careers in Hematology (Private Practice)
60th American Society of Hematology Annual Meeting - 12/1/2018
Immune Thrombocytopenia in US Clinical Practice: Incidence and Healthcare Utilization/Expenditures in the First 12 Months Following Diagnosis
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Outbreak of Synthetic Cannabinoid–Associated Bleeding Disorders in IllinoisSeptember 27th, 2018
FDA Approves Nplate® (Romiplostim) for Use in Pediatric Patients with Immune ThrombocytopeniaJuly 15th, 2008

American Society of Hematology - ASH
Member
American Academy of Pediatrics - AAP
Fellow
American Society of Pediatric Hematology/Oncology
Member
Society for Pediatric Research
Member
International Society for Thrombosis and Hemostasis
Member
National Hemophilia Foundation
Member
Platelet Disorders Support Association
Member
Peoria Medical Society
Member
State Medical Society of Illinois
Member
Medical and Scientific Advisory Council of the National Hemophilia Foundation
Member